New Search

Articles, Chapters, and Reprints
1 A smoking ban in public places increases the efficacy of bupropion and counseling on cessation outcomes at 1 year.
Grassi MC ; Enea D ; Ferketich AK ; Lu B ; Nencini P
Nicotine Tobacco Res 2009;11(9):1114-21     (Journal)     [ PubMed abstract ]
ADAI/UW Link
2 A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics.
Hays JT ; Hurt RD ; Decker PA ; Croghan IT ; Offord KP ; Patten CA
Nicotine Tobacco Res 2009;11(7):859-67     (Journal)     [ PubMed abstract ]
ADAI/UW Link
3 Beliefs and attitudes about bupropion: Implications for medication adherence and smoking cessation treatment.
Fucito LM ; Toll BA ; Salovey P ; O'Malley SS
Psychol Addict Behav 2009;23(2):373-9     (Journal)     [ PubMed abstract ]
UW Link
4 Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
Cornelius JR ; Bukstein OG ; Wood DS ; Kirisci L ; Douaihy A ; Clark DB
Addict Behav 2009;34(10):905-9     (Journal)     [ PubMed abstract ]
UW Link
5 Sustained-release bupropion for hospital-based smoking cessation: a randomized trial.
Simon JA ; Duncan C ; Huggins J ; Solkowitz S ; Carmody TP
Nicotine Tobacco Res 2009;11(6):663-9.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
6 Effects of acute alcohol intoxication and paroxetine on aggression in men.
McCloskey MS ; Berman ME ; Echevarria DJ ; Coccaro EF
Alcohol Clin Exp Res 2009;33(4):581-90.     (Journal)     [ PubMed abstract ]
UW Link
7 Intention to quit moderates the effect of bupropion on smoking urge.
Tidey JW ; Rohsenow DJ
Nicotine Tobacco Res 2009;11(3):308-12.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
8 Varenicline and bupropion sustained-release combination therapy for smoking cessation.
Ebbert JO ; Croghan IT ; Sood A ; Schroeder DR ; Hays JT ; Hurt RD
Nicotine Tobacco Res 2009;11(3):234-9.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
9 A randomized trial of short psychotherapy versus sustained-release bupropion for smoking cessation.
Zernig G ; Wallner R ; Grohs U ; Kriechbaum N ; Kemmler G ; Saria A
Addiction 2008;103(12):2024-31     (Journal)     [ PubMed abstract ]
UW Link
10 A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.
Carpenter KM ; McDowell D ; Brooks DJ ; Cheng WY ; Levin FR
Am J Addict 2009;18(1):53-64     (Journal)     [ PubMed abstract ]
ADAI/UW Link
11 A within-group design of nontreatment seeking 5-HTTLPR genotyped alcohol-dependent subjects receiving ondansetron and sertraline.
Kenna GA ; Zywiak WH ; McGeary JE ; Leggio L ; McGeary C ; Wang S ; Grenga A ; Swift RM
Alcohol Clin Exp Res 2009;33(2):315-23     (Journal)     [ PubMed abstract ]
UW Link
12 Bupropion attenuates methamphetamine self-administration in adult male rats.
Reichel CM ; Murray JE ; Grant KM ; Bevins RA
Drug Alcohol Depend 2009;100(1-2):54-62     (Journal)     [ PubMed abstract ]
UW Link
13 A double-blind, placebo-controlled study of sertraline with naltrexone for alcohol dependence.
Farren CK ; Scimeca M ; Wu R ; Malley SO
Drug Alcohol Depend 2009;99(1-3):317-321     (Journal)     [ PubMed abstract ]
UW Link
14 Canary in a coal mine? Interest in bupropion SR use among smokers in the COMPASS trial.
McClure JB ; Jack L ; Deprey M ; Catz S ; McAfee T ; Zbikowski S ; Westbrook E ; Swan G
Nicotine Tobacco Res 2008;10(12):1815-6     (Journal)     [ PubMed abstract ]
UW Link
15 Psychological mediators of bupropion sustained-release treatment for smoking cessation.
McCarthy DE ; Piasecki TM ; Lawrence DL ; Jorenby DE ; Shiffman S ; Baker TB
Addiction 2008;103(9):1521-33     (Journal)     [ PubMed abstract ]
UW Link
16 Venlafaxine dependence in a patient with a history of alcohol and amineptine misuse.
Quaglio G ; Schifano F ; Lugoboni F
Addiction 2008;103(9):1572-4     (Journal)     [ PubMed abstract ]
UW Link
17 Trazodone for sleep disturbance after alcohol detoxification: a double-blind, placebo-controlled trial.
Friedmann PD ; Rose JS ; Swift R ; Stout RL ; Millman RP ; Stein MD
Alcohol Clin Exp Res 2008;32(9):1652-60     (Journal)     [ PubMed abstract ]
UW Link
18 Mirtazapine, a noradrenergic and specific serotonergic antidepressant, attenuates morphine dependence and withdrawal in Sprague-Dawley rats.
Kang L ; Wang D ; Li B ; Hu M ; Zhang P ; Li J
Am J Drug Alcohol Abuse 2008;34(5):541-52     (Journal)     [ PubMed abstract ]
ADAI/UW Link
19 Does a history of alcohol use disorder affect response to antidepressant medication in patients with dysthymic disorder?
Arnaout B ; Batchelder S ; Rosenthal RN ; Hyler SE ; Hellerstein DJ
J Dual Diagnosis 2008;4(4):377-393     (Journal)     [ ]
ADAI/UW Link
20 Motivational and behavioral factors predicting success in cigarette smoking-cessation treatment combining group therapy with bupropion.
Weinstein A ; Yemini Z ; Greif J
J Groups Addict Recovery 2008;3(1-2):79-92     (Journal)     [ ]
ADAI/UW Link
21 Quetiapine versus trazodone in reducing rehospitalization for alcohol dependence: A large data-base study.
Monnelly EP ; LoCastro JS ; Gagnon D ; Young M ; Fiore LD
J Addict Med 2008;2(3):128-134     (Journal)     [ ]
UW Link
22 Naltrexone alone and with sertraline for the treatment of alcohol dependence in Alaska natives and non-natives residing in rural settings: a randomized controlled trial.
O'Malley SS ; Robin RW ; Levenson AL ; GreyWolf I ; Chance LE ; Hodgkinson CA ; Romano D ; Robinson J ; Meandzija B ; Stillner V ; Wu R ; Goldman D
Alcohol Clin Exp Res 2008;32(7):1271-83     (Journal)     [ PubMed abstract ]
UW Link
23 Preliminary study of buprenorphine and bupropion for opioid-dependent smokers.
Mooney ME ; Poling J ; Gonzalez G ; Gonsai K ; Kosten T ; Sofuoglu M
Am J Addict 2008;17(4):287-92     (Journal)     [ PubMed abstract ]
ADAI/UW Link
24 Randomized, placebo-controlled trial of bupropion for the treatment of methamphetamine dependence.
Shoptaw S ; Heinzerling KG ; Rotheram-Fuller E ; Steward T ; Wang J ; Swanson AN ; De La Garza R ; Newton T ; Ling W
Drug Alcohol Depend 2008;96(3):222-32     (Journal)     [ PubMed abstract ]
UW Link
25 Australian smokers' use of bupropion and nicotine replacement therapies and their relation to reimbursement, Australia 2001-05.
Lutsenko H ; Doran CM ; Hall WD
Drug Alcohol Rev 2008;27(2):160-4     (Journal)     [ PubMed abstract ]
UW Link
26 Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats.
Paterson NE ; Balfour DJ ; Markou A
Nicotine Tobacco Res 2008;10(6):995-1008     (Journal)     [ PubMed abstract ]
ADAI/UW Link
27 Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence.
Shoptaw S ; Heinzerling KG ; Rotheram-Fuller E ; Kao UH ; Wang PC ; Bholat MA ; Ling W
J Addict Dis 2008;27(1):13-23     (Journal)     [ PubMed abstract ]
ADAI/UW Link
28 A randomized controlled clinical trial of bupropion SR and individual smoking cessation counseling.
McCarthy DE ; Piasecki TM ; Lawrence DL ; Jorenby DE ; Shiffman S ; Fiore MC ; Baker TB
Nicotine Tobacco Res 2008;10(4):717-29     (Journal)     [ PubMed abstract ]
ADAI/UW Link
29 Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation.
Schnoll RA ; Epstein L ; Audrain J ; Niaura R ; Hawk L ; Shields PG ; Lerman C ; Wileyto EP
J Subst Abuse Treat 2008;34(2):234-41     (Journal)     [ PubMed abstract ]
UW Link
30 A preliminary investigation of naltrexone augmentation of bupropion to stop smoking with less weight gain.
Toll BA ; Leary V ; Wu R ; Salovey P ; Meandzija B ; O'Malley SS
Addict Behav 2008;33(1):173-9     (Journal)     [ PubMed abstract ]
UW Link
31 Naltrexone is associated with reduced drinking by alcohol dependent patients receiving antidepressants for mood and anxiety symptoms: results from VA Cooperative Study No. 425, "Naltrexone in the treatment of alcoholism".
Krystal JH ; Gueorguieva R ; Cramer J ; Collins J ; Rosenheck R ; VA CSP No 425 Study Team
Alcohol Clin Exp Res 2008;32(1):85-91     (Journal)     [ PubMed abstract ]
UW Link
32 Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: Analysis of pooled data from two clinical trials.
David SP ; Strong DR ; Munafò MR ; Brown RA ; Lloyd-Richardson EE ; Wileyto PE ; Evins EA ; Shields PG ; Lerman C ; Niaura R
Nicotine Tobacco Res 2007;9(12):1251-7     (Journal)     [ PubMed abstract ]
ADAI/UW Link
33 Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: A randomized controlled trial.
Toll BA ; O'Malley SS ; Katulak NA ; Wu R ; Dubin JA ; Latimer A ; Meandzija B ; George TP ; Jatlow P ; Cooney JL ; Salovey P
Psychol Addict Behav 2007;21(4):534-44     (Journal)     [ PubMed abstract ]
UW Link
34 Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats.
Hargreaves GA ; McGregor IS
Alcohol Clin Exp Res 2007;31(11):1900-7.     (Journal)     [ PubMed abstract ]
UW Link
35 A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders.
Riggs PD ; Mikulich-Gilbertson SK ; Davies RD ; Lohman M ; Klein C ; Stover SK
Arch Pediatr Adolesc Med 2007;161(11):1026-1034.     (Online resource)     [ PubMed abstract ]
Free Link
36 Efficacy of bupropion alone and in combination with nicotine gum.
Piper ME ; Federman EB ; McCarthy DE ; Bolt DM ; Smith SS ; Fiore MC ; Baker TB
Nicotine Tobacco Res 2007;9(9):947-54.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
37 Bupropion and cognitive-behavioral treatment for depression in smoking cessation.
Brown RA ; Niaura R ; Lloyd-Richardson EE ; Strong DR ; Kahler CW ; Abrantes AM ; Abrams D ; Miller IW
Nicotine Tobacco Res 2007;9(7):721-30     (Journal)     [ PubMed abstract ]
ADAI/UW Link
38 Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.
David SP ; Brown RA ; Papandonatos GD ; Kahler CW ; Lloyd-Richardson EE ; Munafo MR ; Shields PG ; Lerman C ; Strong D ; McCaffery J ; Niaura R
Nicotine Tobacco Res 2007;9(8):821-33     (Journal)     [ PubMed abstract ]
ADAI/UW Link
39 A randomized trial of bupropion and/or nicotine gum as maintenance treatment for preventing smoking relapse.
Covey LS ; Glassman AH ; Jiang H ; Fried J ; Masmela J ; LoDuca C ; Petkova E ; Rodriguez K
Addiction 2007;102(8):1292-302     (Journal)     [ PubMed abstract ]
UW Link
40 Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients.
Poling J ; Pruzinsky R ; Kosten TR ; Gonsai K ; Sofuoglu M ; Gonzalez G ; Oliveto A
Am J Addict 2007;16(3):187-94     (Journal)     [ PubMed abstract ]
ADAI/UW Link
41 Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial.
Moeller FG ; Schmitz JM ; Steinberg JL ; Green CM ; Reist C ; Lai LY ; Swann AC ; Grabowski J
Am J Drug Alcohol Abuse 2007;33(3):367-78     (Journal)     [ PubMed abstract ]
ADAI/UW Link
42 Bupropion SR for the treatment of smokeless tobacco use.
Dale LC ; Ebbert JO ; Glover ED ; Croghan IT ; Schroeder DR ; Severson HH ; Hurt RD
Drug Alcohol Depend 2007;90(1):56-63.     (Journal)     [ PubMed abstract ]
UW Link
43 Pharmacists on the front line in providing support for nicotine replacement therapy and bupropion purchasers.
Paul CL ; Tzelepis F ; Walsh RA ; Turner R
Drug Alcohol Rev 2007;26(4):429-33.     (Journal)     [ PubMed abstract ]
UW Link
44 Bupropion and cognitive-behavioral therapy for smoking cessation in women.
Schmitz JM ; Stotts AL ; Mooney ME ; Delaune KA ; Moeller GF
Nicotine Tobacco Res 2007;9(6):699-709.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
45 The effect of antidepressant warnings on prescribing trends in Ontario, Canada.
Kurdyak PA ; Juurlink DN ; Mamdani MM
Am J Public Health 2007;97(4):750-4     (Journal)     [ PubMed abstract ]
UW Link
46 Adding MEMS feedback to behavioral smoking cessation therapy increases compliance with bupropion: a replication and extension study.
Mooney ME ; Sayre SL ; Hokanson PS ; Stotts AL ; Schmitz JM
Addict Behav 2007;32(4):875-80     (Journal)     [ PubMed abstract ]
UW Link
47 Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence.
Shoptaw S ; Huber A ; Peck J ; Yang X ; Liu J ; Jeff Dang ; Roll J ; Shapiro B ; Rotheram-Fuller E ; Ling W
Drug Alcohol Depend 2006;85(1):12-8     (Journal)     [ PubMed abstract ]
UW Link
48 Antidepressant treatment patterns in a novel methadone maintenance clinic targeting young adults an observational study.
Galarneau DW ; Teres JJ ; Leon AC ; Melia D ; Lilly C ; Kellogg S ; Khuri E ; Kreek MJ
J Addict Dis 2006;25(2):47-52     (Journal)     [ PubMed abstract ]
ADAI/UW Link
49 Naltrexone with or without fluoxetine for preventing relapse to heroin addiction in St. Petersburg, Russia.
UW Link
50 Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: A five-year follow-up study.
Cornelius JR ; Clark DB ; Bukstein OG ; Birmaher B ; Kelly TM ; Salloum IM ; Walters M ; Matter Sr. J ; Wood DS
J Dual Diagnosis 2005;2(1):11-25     (Journal)     [ ]
ADAI/UW Link
51 Study of the efficacy of fluoxetine and clomipramine in the treatment of premature ejaculation after opioid detoxification.
Abdollahian E ; Javanbakht A ; Javidi K ; Samari AA ; Shakiba M ; Sargolzaee MR
Am J Addict 2006;15(1):100-4     (Journal)     [ PubMed abstract ]
ADAI/UW Link
52 Preexposure to nicotine alters the subsequent locomotor stimulant effects of bupropion in rats.
Wilkinson JL ; Palmatier MI ; Bevins RA
Nicotine Tobacco Res 2006;8(1):141-6     (Journal)     [ PubMed abstract ]
ADAI/UW Link
53 No one listened to imipramine.
Weiss N
IN: Tracy SW ; Acker CJ (eds). ALTERING AMERICAN CONSCIOUSNESS : THE HISTORY OF ALCOHOL AND DRUG USE IN THE UNITED STATES, 1800-2000. Boston : University of Massachusetts Press, 2004, pp.329-352     (Chapter) [Call No: HV 5292 A393 2004]     [ ]
54 Temperament characteristics, as assessed by the tridimensional personality questionnaire, moderate the response to sertraline in depressed opiate-dependent methadone patients.
Raby WN ; Carpenter KM ; Aharonovich E ; Rubin E ; Bisaga A ; Levin F ; Nunes EV
Drug Alcohol Depend 2006;81(3):283-92     (Journal)     [ PubMed abstract ]
UW Link
55 Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
Levin FR ; Evans SM ; Brooks DJ ; Kalbag AS ; Garawi F ; Nunes EV
Drug Alcohol Depend 2006;81(2):137-48     (Journal)     [ PubMed abstract ]
UW Link
56 Tolerance does not develop to the decrease in nicotine self-administration produced by repeated bupropion administration.
Rauhut AS ; Dwoskin LP ; Bardo MT
Nicotine Tobacco Res 2005;7(6):901-7     (Journal)     [ PubMed abstract ]
ADAI/UW Link
57 The influence of depressive symptoms on smoking cessation among African Americans in a randomized trial of bupropion.
Catley D ; Harris KJ ; Okuyemi KS ; Mayo MS ; Pankey E ; Ahluwalia JS
Nicotine Tobacco Res 2005;7(6):859-70     (Journal)     [ PubMed abstract ]
ADAI/UW Link
58 Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.
Cornelius JR ; Clark DB ; Bukstein OG ; Birmaher B ; Salloum IM ; Brown SA
Addict Behav 2005;30(9):1824-33     (Journal)     [ PubMed abstract ]
UW Link
59 Desipramine treatment of cocaine-dependent patients with depression: a placebo-controlled trial.
McDowell D ; Nunes EV ; Seracini AM ; Rothenberg J ; Vosburg SK ; Ma GJ ; Petkova E
Drug Alcohol Depend 2005;80(2):209-21     (Journal)     [ PubMed abstract ]
UW Link
60 A randomized, open-label pilot comparison of gabapentin and bupropion SR for smoking cessation.
White WD ; Crockford D ; Patten S ; El-Guebaly N
Nicotine Tobacco Res 2005;7(5):809-13     (Journal)     [ PubMed abstract ]
ADAI/UW Link
61 Persistence of antidepressant treatment effects in a pharmacotherapy plus psychotherapy trial for active injection drug users.
Stein MD ; Solomon DA ; Anderson BJ ; Herman DS ; Anthony JL ; Brown RA ; Ramsey SE ; Miller IW
Am J Addict 2005;14(4):346-57     (Journal)     [ PubMed abstract ]
ADAI/UW Link
62 A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments.
Winhusen TM ; Somoza EC ; Harrer JM ; Mezinskis JP ; Montgomery MA ; Goldsmith RJ ; Coleman FS ; Bloch DA ; Leiderman DB ; Singal BM ; Berger P ; Elkashef A
Addiction 2005;100 Suppl 1:68-77     (Journal)     [ PubMed abstract ]
UW Link
63 Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence.
Ciraulo DA ; Sarid-Segal O ; Knapp CM ; Ciraulo AM ; LoCastro J ; Bloch DA ; Montgomery MA ; Leiderman DB ; Elkashef A
Addiction 2005;100 Suppl 1:12-22     (Journal)     [ PubMed abstract ]
UW Link
64 Fluoxetine dependence in a former amineptine abuser.
Taieb O ; Larroche C ; Dutray B ; Baubet T ; Moro MR
Am J Addict 2004;13(5):498-500     (Journal)     [ PubMed abstract ]
ADAI/UW Link
65 Double-blind placebo-controlled trial of fluoxetine in smoking cessation treatment including nicotine patch and cognitive-behavioral group therapy.
Saules KK ; Schuh LM ; Arfken CL ; Reed K ; Kilbey MM ; Schuster CR
Am J Addict 2004;13(5):438-46     (Journal)     [ PubMed abstract ]
ADAI/UW Link
66 Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response.
Kosten T ; Sofuoglu M ; Poling J ; Gonsai K ; Oliveto A
Am J Addict 2005;14(1):8-17     (Journal)     [ PubMed abstract ]
ADAI/UW Link
67 Comparison of desipramine or carbamazepine to placebo for crack cocaine-dependent patients.
Campbell J ; Nickel EJ ; Penick EC ; Wallace D ; Gabrielli WF ; Rowe C ; Liskow B ; Powell BJ ; Thomas HM
Am J Addict 2003;12(2):122-36     (Journal)     [ PubMed abstract ]
ADAI/UW Link
68 Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
Cornelius JR ; Clark DB ; Bukstein OG ; Kelly TM ; Salloum IM ; Wood DS
Addict Behav 2005;30(4):807-14     (Journal)     [ PubMed abstract ]
UW Link
69 Sertraline in the treatment of co-occurring alcohol dependence and posttraumatic stress disorder.
Brady KT ; Sonne S ; Anton RF ; Randall CL ; Back SE ; Simpson K
Alcohol Clin Exp Res 2005;29(3):395-401     (Journal)     [ PubMed abstract ]
UW Link
70 Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
Torrens M ; Fonseca F ; Mateu G ; Farre M
Drug Alcohol Depend 2005;78(1):1-22     (Journal)     [ PubMed abstract ]
UW Link
71 Effectiveness of bupropion for smoking cessation during pregnancy.
Chan B ; Einarson A ; Koren G
J Addict Dis 2005;24(2):19-23     (Journal)     [ PubMed abstract ]
ADAI/UW Link
72 Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion.
Wileyto EP ; Patterson F ; Niaura R ; Epstein LH ; Brown RA ; Audrain-McGovern J ; Hawk LW Jr ; Lerman C
Nicotine Tobacco Res 2005;7(2):257-68     (Journal)     [ PubMed abstract ]
ADAI/UW Link
73 Effect of bupropion on depression symptoms in a smoking cessation clinical trial.
Lerman C ; Niaura R ; Collins BN ; Wileyto P ; Audrain-McGovern J ; Pinto A ; Hawk L ; Epstein LH
Psychol Addict Behav 2004;18(4):362-6     (Journal)     [ PubMed abstract ]
UW Link
74 Psychotic symptoms associated with bupropion treatment for smoking cessation.
Khazaal Y ; Kolly S ; Zullino DF
J Subst Use 2005;10(1):62-64     (Journal)     [ ]
ADAI/UW Link
75 Fluoxetine attenuates adrenocortical but not subjective responses to cocaine cues.
Harris DS ; Batki SL ; Berger SP
Am J Drug Alcohol Abuse 2004;30(4):765-82     (Journal)     [ PubMed abstract ]
ADAI/UW Link
76 GP prescribing of nicotine replacement and bupropion to aid smoking cessation in England and Wales.
McEwen A ; West R ; Owen L
Addiction 2004;99(11):1470-4     (Journal)     [ PubMed abstract ]
UW Link
77 Are there gender differences in smoking cessation, with and without bupropion? Pooled- and meta-analyses of clinical trials of Bupropion SR.
Scharf D ; Shiffman S
Addiction 2004;99(11):1462-9     (Journal)     [ PubMed abstract ]
UW Link
78 Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ ; Lebargy F ; Berlin I ; Bidaut-Mazel C ; Chemali-Hudry J ; Lagrue G
Addiction 2004;99(9):1206-18     (Journal)     [ PubMed abstract ]
UW Link
79 Gender differences in response to sertraline pharmacotherapy in Type A alcohol dependence.
Pettinati HM ; Dundon W ; Lipkin C
Am J Addict 2004;13(3):236-47     (Journal)     [ PubMed abstract ]
ADAI/UW Link
80 Antidepressant medication use among First Nations peoples residing within British Columbia.
Wardman D ; Khan N
Am Indian Alsk Native Ment Health Res 2004;11(3):43-8     (Journal)     [ PubMed abstract ]
Free Link
81 Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine.
Wee S ; Woolverton WL
Drug Alcohol Depend 2004;75(3):271-6     (Journal)     [ PubMed abstract ]
UW Link
82 The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial.
Carpenter KM ; Brooks AC ; Vosburg SK ; Nunes EV
Drug Alcohol Depend 2004;74(2):123-34     (Journal)     [ PubMed abstract ]
UW Link
83 Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology.
Chick J ; Aschauer H ; Hornik K
Drug Alcohol Depend 2004;74(1):61-70     (Journal)     [ PubMed abstract ]
UW Link
84 A multicenter, randomized, double-blind, placebo-controlled, 6-month trial of bupropion hydrochloride sustained-release tablets as an aid to smoking cessation in hospital employees.
Dalsgareth OJ ; Hansen NC ; Soes-Petersen U ; Evald T ; Hoegholm A ; Barber J ; Vestbo J
Nicotine Tobacco Res 2004;6(1):55-61     (Journal)     [ PubMed abstract ]
ADAI/UW Link
85 Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling.
Collins BN ; Wileyto EP ; Patterson F ; Rukstalis M ; Audrain-McGovern J ; Kaufmann V ; Pinto A ; Hawk L ; Niaura R ; Epstein LH ; Lerman C
Nicotine Tobacco Res 2004;6(1):27-37     (Journal)     [ PubMed abstract ]
ADAI/UW Link
86 Do small lapses predict relapse to smoking behavior under bupropion treatment?
Wileyto P ; Patterson F ; Niaura R ; Epstein L ; Brown R ; Audrain-McGovern J ; Hawk L ; Lerman C ; Patterson F
Nicotine Tobacco Res 2004;6(2):357-66     (Journal)     [ PubMed abstract ]
ADAI/UW Link
87 Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.
Kosten T ; Falcioni J ; Oliveto A ; Feingold A
Am J Addict 2004;13(2):191-201     (Journal)     [ PubMed abstract ]
ADAI/UW Link
88 Bupropion in breast milk: an exposure assessment for potential treatment to prevent post-partum tobacco use.
Haas JS ; Kaplan CP ; Barenboim D ; Jacob P 3rd ; Benowitz NL
Tobacco Control 2004;13(1):52-6     (Journal)     [ PubMed abstract ]
UW Link
89 Does the DRD2-Taq1 A polymorphism influence treatment response to bupropion hydrochloride for reduction of the nicotine withdrawal syndrome?
David SP ; Niaura R ; Papandonatos GD ; Shadel WG ; Burkholder GJ ; Britt DM ; Day A ; Stumpff J ; Hutchison K ; Murphy M ; Johnstone E ; Griffiths SE ; Walton RT
Nicotine Tobacco Res 2003;5(6):935-42     (Journal)     [ PubMed abstract ]
ADAI/UW Link
90 Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome.
Swan GE ; Jack LM ; Curry S ; Chorost M ; Javitz H ; McAfee TT ; Dacey S
Nicotine Tobacco Res 2003;5(6):911-21     (Journal)     [ PubMed abstract ]
ADAI/UW Link
91 Antidepressants and suicidality in youth: Reflections from adult mood disorder specialists.
Dago P ; Gilmer WS
Behav Health Manage 2004;24(1):S3-S4     (Journal)     [ ]
UW Link
92 Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome.
Hurt RD ; Wolter TD ; Rigotti N ; Hays JT ; Niaura R ; Durcan MJ ; Gonzales D ; Sachs DP ; Johnston JA ; Offord KP
Addict Behav 2002;27(4):493-507.     (Journal)     [ PubMed abstract ]
UW Link
93 Does menthol attenuate the effect of bupropion among African American smokers?
Okuyemi KS ; Ahluwalia JS ; Ebersole-Robinson M ; Catley D ; Mayo MS ; Resnicow K
Addiction 2003;98(10):1387-93     (Journal)     [ PubMed abstract ]
UW Link
94 Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
Gonzalez G ; Feingold A ; Oliveto A ; Gonsai K ; Kosten TR
Am J Drug Alcohol Abuse 2003;29(3):497-514     (Journal)     [ PubMed abstract ]
ADAI/UW Link
95 Fluvoxamine as an adjunct to promote methadone dose optimization.
DeMaria PA Jr ; Patkar AA ; Vassos K
Addict Disorders Treat 2003;2(3):85-89     (Journal)     [ ]
UW Link
96 Naltrexone-bupropion combination therapy for protracted abstinence dysphoria.
Williams J ; Ziedonis DM
Am J Addict 2003;12(3):270-2.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
97 Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
Kosten T ; Oliveto A ; Feingold A ; Poling J ; Sevarino K ; McCance-Katz E ; Stine S ; Gonzalez G ; Gonsai K
Drug Alcohol Depend 2003;70(3):315-25     (Journal)     [ PubMed abstract ]
UW Link
98 Review of bupropion for smoking cessation.
Richmond R ; Zwar N
Drug Alcohol Rev 2003;22(2):203-20     (Journal)     [ PubMed abstract ]
UW Link
99 Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients.
Kosten T ; Poling J ; Oliveto A
Addiction 2003;98(5):665-71     (Journal)     [ PubMed abstract ]
UW Link
100 Are antidepressants addictive?
Dean AJ
Drug Alcohol Rev 2002;21(4):317-319     (Journal)     [ PubMed abstract ]
UW Link
101 Seizure associated with sleep deprivation and sustained-release bupropion.
Oncken CA ; Duckrow RB
Nicotine Tobacco Res 2003;5(1):131-3.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
102 Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care.
Gold PB ; Rubey RN ; Harvey RT
Am J Addict 2002;11(4):315-31.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
103 Hormone responses to citalopram in abstinent alcohol dependent subjects.
Gotjen D ; Szabo Z ; Lee S ; Wand G
Alcohol Clin Exp Res 2002;26(11):1625-31.     (Journal)     [ PubMed abstract ]
UW Link
104 Effects of citalopram treatment of protracted withdrawal (syndrome of anhedonia) in patients with heroin addiction.
Krupitsky EM ; Burakov AM ; Didenko TY ; Romanova TN ; Grinenko NI ; Slavina TY ; Grinenko AY ; Tcheremissine OV
Addict Disorders Treat 2002;1(1):29-33     (Journal)     [ ]
UW Link
105 An exploratory study: the use of paroxetine for methamphetamine craving.
Piasecki MP ; Steinagel GM ; Thienhaus OJ ; Kohlenberg BS
J Psychoactive Drugs 2002;34(3):301-4.     (Journal)     [ PubMed abstract ]
106 Bupropion for the treatment of nicotine dependence in spit tobacco users: a pilot study.
Dale LC ; Ebbert JO ; Schroeder DR ; Croghan IT ; Rasmussen DF ; Trautman JA ; Cox LS ; Hurt RD
Nicotine Tobacco Res 2002;4(3):267-74     (Journal)     [ PubMed abstract ]
ADAI/UW Link
107 A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence.
Farren CK ; O'Malley S
Am J Addict 2002;11(3):228-34.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
108 Mediating mechanisms for the impact of bupropion in smoking cessation treatment.
Lerman C ; Roth D ; Kaufmann V ; Audrain J ; Hawk L ; Liu A ; Niaura R ; Epstein L
Drug Alcohol Depend 2002;67(2):219-23.     (Journal)     [ PubMed abstract ]
UW Link
109 Clomipramine increases the striatal concentrations of dopamine and homovanillic acid in rats chronically consuming alcohol.
Palencia G ; Rios C ; Sotelo J
J Stud Alcohol 2001;62(6):724-9     (Journal)     [ PubMed abstract ]
ADAI/UW Link
110 Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence.
Montoya ID ; Preston KL ; Rothman R ; Gorelick DA
Am J Drug Alcohol Abuse 2002;28(1):189-96.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
111 Bupropion treatment for cocaine abuse and adult attention-deficit/hyperactivity disorder.
Levin FR ; Evans SM ; McDowell DM ; Brooks DJ ; Nunes E
J Addict Dis 2002;21(2):1-16     (Journal)     [ PubMed abstract ]
ADAI/UW Link
112 Utility of crossover designs in clinical trials: Efficacy of desipramine vs.placebo in opioid-dependent cocaine abusers.
Feingold A ; Oliveto A ; Schottenfeld R ; Kosten TR
Am J Addict 2002;11(2):111-23.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
113 A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia.
Evins AE ; Mays VK ; Rigotti NA ; Tisdale T ; Cather C ; Goff DC
Nicotine Tobacco Res 2001;3(4):397-403     (Journal)     [ PubMed abstract ]
ADAI/UW Link
114 Fluoxetine in adolescents with major depression and an alcohol use disorder: an open-label trial.
Cornelius JR ; Bukstein OG ; Birmaher B ; Salloum IM ; Lynch K ; Pollock NK ; Gershon S ; Clark D
Addict Behav 2001;26(5):735-9.     (Journal)     [ PubMed abstract ]
UW Link
115 Mass media representations as drug information for patients: the prozac phenomenon.
Montagne M
Subst Use Misuse 2001;36(9-10):1261-74     (Journal)     [ PubMed abstract ]
ADAI/UW Link
116 Alcohol, antidepressants, and circadian rhythms. Human and animal models.
Rosenwasser AM.
Alcohol Res Health 2001;25(2):126-35.     (Journal)     [ ]
Free Link
117 Relationship between drug exposure and the efficacy and safety of bupropion sustained release for smoking cessation.
Johnston JA ; Fiedler-Kelly J ; Glover ED ; Sachs DP ; Grasela TH ; DeVeaugh-Geiss J
Nicotine Tobacco Res 2001;3(2):131-40     (Journal)     [ PubMed abstract ]
ADAI/UW Link
118 Relationship between central serotonergic neurotransmission and reduction in alcohol intake by citalopram.
Berggren U ; Eriksson M ; Fahlke C ; Balldin J
Drug Alcohol Depend 2001;63(3):263-7.     (Journal)     [ PubMed abstract ]
UW Link
119 Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers.
Oliveto A ; McCance-Katz FE ; Singha A ; Petrakis I ; Hameedi F ; Kosten TR
Drug Alcohol Depend 2001;63(2):155-67.     (Journal)     [ PubMed abstract ]
UW Link
120 Fluoxetine treatment of cocaine-dependent patients with major depressive disorder.
Schmitz JM ; Averill P ; Stotts AL ; Moeller FG ; Rhoades HM ; Grabowski J
Drug Alcohol Depend 2001;63(3):207-14.     (Journal)     [ PubMed abstract ]
UW Link
121 Fluoxetine versus placebo in depressed alcoholics: a 1-year follow-up study.
Cornelius JR ; Salloum IM ; Haskett RF ; Daley DC ; Cornelius MD ; Thase ME ; Perel JM
Addict Behav 2000;25(2):307-10     (Journal)     [ PubMed abstract ]
UW Link
122 Combined use of trazodone-naltrexone versus clonidine-naltrexone in rapid withdrawal from methadone treatment. A comparative inpatient study.
Pozzi G ; Conte G ; De Risio S
Drug Alcohol Depend 2000;59(3):287-94.     (Journal)     [ PubMed abstract ]
UW Link
123 The effect of sertraline on methadone plasma levels in methadone-maintenance patients.
Hamilton SP ; Nunes EV ; Janal M ; Weber L
Am J Addict 2000;9(1):63-9.     (Journal)     [ PubMed abstract ]
ADAI/UW Link
124 Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype.
Pettinati HM ; Volpicelli JR ; Kranzler HR ; Luck G ; Rukstalis MR ; Cnaan A
Alcohol Clin Exp Res 2000;24(7):1041-9     (Journal)     [ PubMed abstract ]
UW Link
125 Venlafaxine treatment of cocaine abusers with depressive disorders.
McDowell DM ; Levin FR ; Seracini AM ; Nunes EV
Am J Drug Alcohol Abuse 2000; 26(1): 25-31     (Journal)     [ PubMed abstract ]
ADAI/UW Link
126 Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats.
Rezvani AH ; Overstreet DH ; Mason GA ; Janowsky DS ; Hamedi M ; Clark E Jr ; Yang Y
Alcohol Alcoholism 2000; 35(1): 76-83     (Journal)     [ ]
UW Link
127 The use of antidepressants among injecting drug users in Sydney, Australia.
Darke S ; Ross J
Addiction 2000; 95(3): 407-17     (Journal)     [ PubMed abstract ]
UW Link
128 The effects of fluoxetine combined with nicotine inhalers in smoking cessation--a randomized trial.
Blondal T ; Gudmundsson LJ ; Tomasson K ; Jonsdottir D ; Hilmarsdottir H ; Kristjansson F ; Nilsson F ; Bjornsdottir US
Addiction 1999; 94(7): 1007-15     (Journal)     [ PubMed abstract ]
UW Link
129 A therapeutic use of the methadone fluvoxamine drug interaction.
DeMaria PA Jr ; Serota RD
J Addict Dis 1999; 18(4): 5-12     (Journal)     [ PubMed abstract ]
ADAI/UW Link
130 The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group.
Meszaros K ; Lenzinger E ; Hornik K ; Fureder T ; Willinger U ; Fischer G ; Schonbeck G ; Aschauer HN
Alcohol Clin Exp Res 1999;23(3):483-6     (Journal)     [ PubMed abstract ]
UW Link
131 Comparison of the effects of the selective serotonin-reuptake inhibitors fluoxetine, paroxetine, citalopram and fluvoxamine in alcohol-preferring cAA rats.
Maurel S ; De Vry J ; Schreiber R
Alcohol 1999;17(3):195-201     (Journal)     [ ]
UW Link
132 Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
Cornelius JR ; Salloum IM ; Haskett RF ; Ehler JG ; Jarrett PJ ; Thase ME ; Perel JM
Addict Behav 1999;24(1):111-4     (Journal)     [ PubMed abstract ]
UW Link
133 A treatment algorithm for attention deficit hyperactivity disorder in cocaine-dependent adults : a one-year private practice study with long-acting stimulants, fluoxetine, and bupropion.
Castaneda R ; Sussman N ; Levy R ; Trujillo M
Subst Abuse 1999;20(1):59-71     (Journal)     [ PubMed abstract ]
ADAI/UW Link
134 A randomized trial of adding fluoxetine to a naltrexone treatment programme for heroin addicts.
Landabaso MA ; Iraurgi I ; Jimenez-Lerma JM ; Sanz J ; Fernadez de Corres B ; Araluce K ; Calle R ; Gutierrez-Fraile M
Addiction 1998;93(5):739-44     (Journal)     [ PubMed abstract ]
UW Link
135 Adjuvant trazodone in the treatment of alcoholism: an open study.
Janiri L ; Hadjichristos A ; Buonanno A ; Rago R ; Mannelli P ; de Risio S
Alcohol Alcoholism 1998;33(4):362-5     (Journal)     [ ]
UW Link
136 Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.
Petrakis I ; Carroll KM ; Nich C ; Gordon L ; Kosten T ; Rounsaville B
Drug Alcohol Depend 1998;50(3):221-6     (Journal)     [ PubMed abstract ]
UW Link
137 Citalopram as an inhibitor of voluntary ethanol intake in the male rat.
Hedlund L ; Wahlstrom G
Alcohol 1998;16(4):295-303     (Journal)     [ ]
UW Link
138 Combination of naltrexone and fluoxetine on rats' propensity to take alcoholic beverage.
Gardell LR ; Whalen CA ; Chattophadyay S ; Cavallaro CA ; Hubbell CL ; Reid LD
Alcohol Clin Exp Res 1997;21(8):1435-9     (Journal)     [ ]
UW Link
139 Effects of fluvoxamine and citalopram in maintaining abstinence in a sample of Italian detoxified alcoholics.
Angelone SM ; Bellini L ; Di Bella D ; Catalano M
Alcohol Alcoholism 1998;33(2):151-6     (Journal)     [ ]
UW Link
140 Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
Zhou FC ; McKinzie DL ; Patel TD ; Lumeng L ; Li TK
Alcohol Clin Exp Res 1998;22(1):266-9     (Journal)     [ ]
UW Link
141 Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in type B alcoholics.
Kranzler HR ; Burleson JA ; Brown J ; Babor TF
Alcohol Clin Exp Res 1996;20(9):1534-41     (Journal)     [ ]
142 A controlled trial of imipramine for the treatment of methamphetamine dependence.
Galloway GP ; Newmeyer J ; Knapp T ; Stalcup SA ; Smith D
J Subst Abuse Treat 1996;13(6):493-7     (Journal)     [ PubMed abstract ]
UW Link
143 Sedative-hypnotics and tricyclics.
Wesson DR ; Smith DE ; Ling W ; Seymour RB
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE : A COMPREHENSIVE TEXTBOOK, THIRD EDITION. Philadelphia: Williams & Wilkins, 1997, p. 223-230     (Chapter) [Call No: RC 564 S826 1997 [REF HAND]]     [ ]
144 Trazodone for the treatment of depression in alcoholics [letter]
Hershberg PI
J Subst Abuse Treat 1995;12(4):297     (Journal)     [ PubMed abstract ]
UW Link
145 Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
Oliveto A ; Kosten TR ; Schottenfeld R ; Falcioni J ; Ziedonis D
J Subst Abuse Treat 1995;12(6):423-8     (Journal)     [ PubMed abstract ]
UW Link
146 A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients.
Margolin A ; Kosten TR ; Avants SK ; Wilkins J ; Ling W ; Beckson M ; Arndt IO ; Cornish J ; Ascher JA ; Li SH ; et al
Drug Alcohol Depend 1995;40(2):125-31     (Journal)     [ PubMed abstract ]
UW Link
147 The chemistry of mood : A look at the phenomenal impact brain chemistry, serotonin, and drugs such as Prozac are having on the treatment of anxiety, depression, and other disorders.
Norden MJ
Professional Counselor 1997;12(1):27-32     (Journal)     [ ]
148 A controlled trial of fluoxetine in crack cocaine dependence.
Batki SL ; Washburn AM ; Delucchi K ; Jones RT
Drug Alcohol Depend 1996;41(2):137-42     (Journal)     [ PubMed abstract ]
UW Link
149 A placebo-controlled, double-blind study of fluoxetine in severe alcohol dependence: adjunctive pharmacotherapy during and after inpatient treatment.
Kabel DI ; Petty F
Alcohol Clin Exp Res 1996;20(4):780-4     (Journal)     [ ]
150 Predictors of antidepressant response in depressed alcoholic patients.
Nunes EV ; McGrath PJ ; Quitkin FM ; Stewart JW ; Goehl L ; Ocepek-Welikson K
Am J Addict 1996;5(4):308-312     (Journal)     [ ]
ADAI/UW Link
151 Cardiovascular interactions of desipramine, fluxetine, and cocaine-dependent outpatients.
Nelson RA ; Gorelick DA ; Keenan RM ; Carmona GN ; Covi L
Am J Addict 1996;5(4):321-326     (Journal)     [ ]
ADAI/UW Link
152 Imipramine treatment of cocaine abuse: possible boundaries of efficacy.
Nunes EV ; McGrath PJ ; Quitkin FM ; Ocepek-Welikson K ; Stewart JW ; Koenig T ; Wager S ; Klein DF
Drug Alcohol Depend 1995;39(3):185-95     (Journal)     [ PubMed abstract ]
UW Link
153 Acute subjective responses to paroxetine in normal volunteers.
Brauer LH ; Rukstalis MR ; de Wit H
Drug Alcohol Depend 1995;39(3):223-30     (Journal)     [ PubMed abstract ]
UW Link
154 Effects of combined fluoxetine and counseling in the outpatient treatment of cocaine abusers.
Covi L ; Hess JM ; Kreiter NA ; Haertzen CA
Am J Drug Alcohol Abuse 1995;21(3):327-44     (Journal)     [ PubMed abstract ]
ADAI/UW Link
155 Safety and efficacy of bupropion combined with bromocriptine for treatment of cocaine dependence.
Montoya ID ; Preston KL ; Cone EJ ; Rothman R ; Gorelick DA
Am J Addict 1996;5(1):69-75     (Journal)     [ ]
ADAI/UW Link
156 Effects of sertraline in the treatment of alcoholism.
Bogenschutz MP ; Nurnberg HG
Am J Addict 1996;5(1):91     (Journal)     [ ]
ADAI/UW Link
157 Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence.
Brady KT ; Sonne SC ; Roberts JM
J Clin Psychiatry 1995;56(11):502-505     (Reprint 08020)     [ ]
158 Selective serotonin reuptake inhibitors: effects of chronic treatment on ethanol-reinforced behavior in mice.
Gulley JM ; McNamara C ; Barbera TJ ; Ritz MC ; George FR
Alcohol 1995;12(3):177-81     (Journal)     [ ]
UW Link
159 Treatment of crack-cocaine-induced compulsive behavior with trazodone.
Khouzam HR ; Mayo-Smith MF ; Bernard DR ; Mahdasian JA
J Subst Abuse Treat 1995;12(2):85-8     (Journal)     [ PubMed abstract ]
UW Link
160 Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence : Two placebo-controlled double-blind trials.
Grabowski J ; Rhoades H ; Elk R ; Schmitz J ; Davis C ; Creson D ; Kirby K
J Clin Psychopharmacology 1995;15(3):163-174     (Reprint 08218)     [ ]
161 Fluoxetine improves outcome in addicted patients treated with opioid antagonists.
Maremmani I ; Zolesi O ; Daini L ; Castrogiovanni P ; Tagliamonte A
Am J Addict 1995;4(3):267-271     (Journal)     [ ]
ADAI/UW Link
162 Antidepressant treatment in methadone maintenance patients.
Nunes E ; Quitkin F ; Brady R ; Post-Koenig T
J Addict Dis 1994;13(3):13-24     (Journal)     [ PubMed abstract ]
ADAI/UW Link
163 Imipramine for the treatment of cocaine and methamphetamine dependence.
Galloway GP ; Newmeyer J ; Knapp T ; Stalcup SA ; Smith D
J Addict Dis 1994;13(4):201-16     (Journal)     [ PubMed abstract ]
ADAI/UW Link
164 Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings.
Campbell JL ; Thomas HM ; Gabrielli W ; Liskow BI ; Powell BJ
J Addict Dis 1994;13(4):191-9     (Journal)     [ PubMed abstract ]
ADAI/UW Link
165 Fluoxetine treatment for dually diagnosed methadone maintained opioid addicts: a pilot study.
Petrakis I ; Carroll K ; Gordon L ; Cushing G ; Rounsaville B
J Addict Dis 1994;13(3):25-32     (Journal)     [ PubMed abstract ]
ADAI/UW Link
166 Effects of citalopram and a brief psycho-social intervention on alcohol intake, dependence and problems.
Naranjo CA ; Bremner KE ; Lanctot KL
Addiction 1995;90(1):87-99     (Journal)     [ PubMed abstract ]
167 Effect of citalopram on alcohol intake in heavy drinkers.
Balldin J ; Berggren U ; Engel J ; Eriksson M ; Hard E ; Soderpalm B
Alcohol Clin Exp Res 1994;18(5):1133-6     (Journal)     [ ]
168 Toxic delirium in an alcohol patient treated with antidepressants: usefulness of measurement of plasma levels for differential diagnosis: Case report.
Soyka M ; Holzbach R ; Kuss HJ
Eur Addict Res 1995;1(1/2):74-75     (Journal)     [ ]
169 Comparison of the action of the 5-HT2 antagonists amperozide and trazodone on preference for alcohol in rats.
McMillen BA ; Walter S ; Williams HL ; Myers RD
Alcohol 1994;11(3):203-6     (Journal)     [ ]
170 Ethanol consumption following acute treatment with methysergide, fluoxetine, fenfluramine, and their combination.
Lu MR ; Wagner GC ; Fisher H
Alcohol Clin Exp Res 1994;18(1):60-3     (Journal)     [ ]
171 Abuse of monoamine oxidase inhibitors [letter]
Briggs NC ; Jefferson JW
Am J Drug Alcohol Abuse 1994;20(1):125     (Journal)     [ PubMed abstract ]
ADAI/UW Link
172 Adverse effects limit the usefulness of fluvoxamine for the treatment of alcoholism.
Kranzler HR ; Del Boca F ; Korner P ; Brown J
J Subst Abuse Treat 1993;10(3):283-7     (Journal)     [ PubMed abstract ]
173 Desipramine facilitation of initial cocaine abstinence.
Gawin FH ; Kleber HD ; Byck R ; Rounsaville BJ ; Kosten TR ; Jatlow PI ; Morgan C
In: Langenbucher JW ; McCrady BS ; Frankenstein W ; Nathan PE (eds.) ANNUAL REVIEW OF ADDICTIONS RESEARCH AND TREATMENT, vol. 2. New York : Pergamon Press, 1992, pp.313-322     (Chapter) [Call No: RC 533 A55 v.2]     [ ]
174 Platelet paroxetine binding in alcoholics.
Mellerup ET ; Bech P ; Lauritzen L ; Lunde M ; Plenge P
Alcohol Alcoholism 1992;27(6):603-6     (Journal)     [ ]
175 Sedative-hypnotics and tricyclics.
Wesson DR ; Smith DE ; Seymour RB
In: Lowinson JH ; Ruiz P ; Millman RB ; Langrod JG (eds.) SUBSTANCE ABUSE: A COMPREHENSIVE TEXTBOOK. (2nd edition) Baltimore : Williams & Wilkins, 1992. pp.271-279     (Chapter) [Call No: RC 564 S826 1992]     [ ]
176 Ethanol intake of chickens treated with fenfluramine, fluoxetine, and dietary tryptophan.
Lu MR ; Wagner GC ; Fisher H
Alcohol Clin Exp Res 1992;16(5):852-6     (Journal)     [ ]
177 An open trial of sertraline for cocaine abuse.
Kosten TA ; Kosten TR ; Gawin FH ; Gordon LT ; Hogan I ; Kleber HD
Am J Addict 1992;1(4):349-353     (Journal)     [ ]
ADAI/UW Link
178 Abuse of monoamine oxidase inhibitors.
Baumbacher G ; Hansen MS
Am J Drug Alcohol Abuse 1992;18(4):399-406     (Journal)     [ PubMed abstract ]
ADAI/UW Link
179 Fluoxetine treatment of nonparaphilic sexual addictions and paraphilias in men.
Kafka MP ; Prentky R
J Clin Psychiatry 1992;53(10):351-358     (Reprint 05621)     [ ]
180 Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers.
Naranjo CA ; Poulos CX ; Bremmer KE ; Lanctot KL
Clin Pharmacol Ther 1992;51(6):729-739     (Reprint 05535)     [ ]
181 Assessment of dopamine release by in vivo microdialysis in the nucleus accumbens of rats following acute and chronic administration of desipramine.
See RE ; Adams-Curtis L ; Chapman MA
Ann N Y Acad Sci 1992 Jun 28;654:522-4     (Chapter) [Call No: Q11 N5 vol. 654]     [ ]
182 Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine.
Kolar AF ; Brown BS ; Weddington WW ; Haertzen CC ; Michaelson BS ; Jaffe JH
Int J Addict 1992;27(7):849-68     (Journal)     [ ]
ADAI/UW Link
183 Effects of imipramine and ethanol on the activity of a neuronal L-type calcium channel.
McArdle JJ ; Choi JJ ; Huang GJ
Ann N Y Acad Sci 1992 Jun 28;654:477-9     (Chapter) [Call No: Q11 N5 vol. 654]     [ ]
184 Effect of fluoxetine on alcohol consumption in male alcoholics.
Gorelick DA ; Paredes A
Alcohol Clin Exp Res 1992;16(2):261-5     (Journal)     [ ]
185 Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction.
Levin FR ; Lehman AF
J Clin Psychopharmacol 1991;11:374-8     (Reprint 05151)     [ ]
186 A case of a chemically dependent patient with a thalamic pain syndrome treated with amitriptyline.
Kluger NJ ; Clifford JS ; Cavanagh RJ ; Griffith WL
J Addict Dis 1991;10(3):97-102     (Journal)     [ PubMed abstract ]
ADAI/UW Link
187 Preclinical evaluation of the effects of buprenorphine, naltrexone and desipramine on cocaine self-administration.
Mello NK
NIDA Res Monogr 1991;105:189-95     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
188 Concurrent effects of acute intravenous cocaine in context of chronic desipramine in humans.
Pickett G ; Kosten TR ; Gawin FH ; Byck R ; Fleming J ; Silverman D ; Kosten TA ; Jatlow P
NIDA Res Monogr 1991;105:508-9     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
189 An open pilot study of bupropion and psychotherapy for the treatment of cocaine abuse in methadone-maintained patients.
Margolin A ; Kosten T ; Petrakis I ; Avants SK ; Kosten T
NIDA Res Monogr 1991;105:367-8     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
190 Fluoxetine for cocaine abuse in methadone patients: preliminary findings.
Batki SL ; Manfredi LB ; Sorensen JL ; Jacob P ; Dumontet R ; Jones RT
NIDA Res Monogr 1991;105:516-7     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
191 Amantadine and desipramine in the treatment of cocaine abusing methadone maintained patients.
Kosten TR ; Morgan CH ; Schottenfeld RS
NIDA Res Monogr 1991;105:510-1     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
192 Evidence for high and low affinity [3H]cocaine binding sites associated with the serotonin reuptake complex in guinea pig brain: allosteric modulation by paroxetine.
Akunne H ; deCosta BR ; Rice KC ; Jacobson AE ; Rothman RB
NIDA Res Monogr 1991;105:547-8     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
193 Cocaine interaction with sulpiride, methysergide, naloxone and desipramine: neurophysiological effects of mesolimbic and neostriatal neuronal activity.
Dougherty PM ; Qiao JT ; Wiggins RC ; Dafny N
NIDA Res Monogr 1991;105:612-4     (Chapter) [Call No: HV 5825 C617 1990]     [ ]
Free Link
194 Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.
Weddington WW Jr ; Brown BS ; Haertzen CA ; Hess JM ; Mahaffey JR ; Kolar AF ; Jaffe JH
Am J Drug Alcohol Abuse 1991;17(2):137-52     (Journal)     [ PubMed abstract ]
ADAI/UW Link
195 Fluoxetine-induced suicidality, serotonin, and seasonality.
Brewerton TD
Biol Psychiatry 1991;30:190-6     (Reprint 04900)     [ ]
196 Fluoxetine treatment of cocaine abuse in heroin addicts.
Pollack MH ; Rosenbaum JF
J Clin Psychiatry 1990;52(1):31-3     (Reprint 04714)     [ ]
197 Fluoxetine and obsessive-compulsive disorder: a naturalistic study.
Wilcox JA
J Psychoactive Drugs 1990;22(3):355-6     (Journal)     [ PubMed abstract ]
198 Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.
Kosten TR ; Gawin FH ; Morgan C ; Nelson JC ; Jatlow P
Am J Drug Alcohol Abuse 1990;16(3-4):329-36     (Journal)     [ PubMed abstract ]
ADAI/UW Link
199 Effects of fluoxetine and desipramine on palatability-induced ethanol consumption in the alcohol-nonpreferring (NP) line of rats.
Gatto GJ ; Murphy JM ; McBride WJ ; Lumeng L ; Li TK
Alcohol 1990;7(6):531-6     (Journal)     [ ]
200 Desipramine effects on cocaine self-administration by rhesus monkeys.
Mello NK ; Lukas SE ; Bree MP ; Mendelson JH
Drug Alcohol Depend 1990;26(2):103-16     (Journal)     [ PubMed abstract ]
201 Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: a preliminary study.
Stapleton JM ; Eckardt MJ ; Martin P ; Adinoff B ; Roehrich L ; Bone G ; Rubinow D ; Linnoila M
In: Gordis E ; Tabakoff B ; Linnoila M (eds.) ALCOHOL RESEARCH FROM BENCH TO BEDSIDE. New York : Haworth Press, 1990, pp. 47-51.     (Chapter) [Call No: RC 565 A4444 1988]     [ ]
202 Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor.
Gleiter CH ; Nutt DJ
In: Gordis E ; Tabakoff B ; Linnoila M (eds.) ALCOHOL RESEARCH FROM BENCH TO BEDSIDE. New York : Haworth Press, 1990, pp. 107-11.     (Chapter) [Call No: RC 565 A4444 1988]     [ ]
203 Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.
Weddington WW ; Brown BS ; Haertzen CA ; Hess JM ; Kolar AF ; Mahaffey JR
NIDA Res Monogr 1989;95:483-4     (Chapter) [Call No: HV 5825 C617 1989]     [ ]
Free Link
204 Desipramine treatment for relapse prevention in cocaine dependence.
McElroy SL ; Weiss RD ; Mendelson JH ; Teoh SK ; McAfee B ; Mello NK
NIDA Res Monogr 1989;95:57-63     (Chapter) [Call No: HV 5825 C617 1989]     [ ]
Free Link
205 Desipramine treatment of cocaine abuse in methadone maintenance patients.
Arndt I ; Dorozynsky L ; Woody G ; McLellan AT ; O'Brien CP
NIDA Res Monogr 1989;95:322-3     (Chapter) [Call No: HV 5825 C617 1989]     [ ]
Free Link
206 Schedule-induced oral self-administration of cocaine and ethanol solutions: lack of effect of chronic desipramine.
Tang M ; Falk JL
Drug Alcohol Depend 1990;25(1):21-5     (Journal)     [ PubMed abstract ]
207 Fluoxetine and bulimia.
Wilcox JA
J Psychoactive Drugs 1990;22(1):81-2     (Journal)     [ PubMed abstract ]
208 Do some antidepressants help control drinking behavior?
Schuckit MA
Drug Abuse Alcohol Newsl 1990;19(3):1-4     (Newsletter)     [ ]
209 Tricyclic antidepressants in the treatment of alcoholism and drug abuse.
Weiss RD
J Clin Psychiatry 1989;50(7,Suppl):4-9     (Reprint 03879)     [ ]
210 Addiction to tranylcypromine (Parnate): a case report.
Westermeyer J
Am J Drug Alcohol Abuse 1989;15(3):345-50     (Journal)     [ ]
ADAI/UW Link
211 Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics.
Schottenfeld RS ; O'Malley SS ; Smith L ; Rounsaville BJ ; Jaffe JH
Am J Drug Alcohol Abuse 1989;15(3):339-44     (Journal)     [ ]
ADAI/UW Link
212 Platelets of alcoholics, and of subjects genetically at risk for alcoholism, share the same abnormality of imipramine binding sites [letter]
Suranyi-Cadotte B ; Dongier M ; Lafaille F ; Luthe L
Br J Addict 1989;84(4):437-8     (Journal)     [ ]
UW Link
213 Effect of low alcohol dose on behavioral "despair: in rats neonatally treated with antidepressant drugs.
Fernandez-Pardal J ; Hilakivi LA
Alcohol 1989;6(2):93-5     (Journal)     [ ]
214 Desipramine facilitation of initial cocaine abstinence.
Gawin FH ; Kleber HD ; Byck R ; Rounsaville BJ ; Kosten TR ; Jatlow PI ; Morgan C
Arch Gen Psychiatry 1989;46:117-121     (Reprint 03528)     [ ]
215 Cocaine abuse treated with phenelzine.
Golwyn DH
Int J Addict 1988;23(9):897-905     (Journal)     [ ]
ADAI/UW Link
216 Treatment of alcoholic organic brain syndrome with the serotonin reuptake inhibitor fluvoxamine: a preliminary study.
Stapleton JM ; Eckardt MJ ; Martin P ; Adinoff B ; Roehrich L ; Bone G ; Rubinow D ; Linnoila M
Adv Alcohol Subst Abuse 1988;7(3-4):47-51     (Journal)     [ ]
217 Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor.
Gleiter CH ; Nutt DJ
Adv Alcohol Subst Abuse 1988;7(3-4):107-11     (Journal)     [ ]
218 A further examination of the effects of sertraline on voluntary ethanol consumption.
Gill K ; Filion Y ; Amit Z
Alcohol 1988;5(5):355-8     (Journal)     [ ]
219 Treatment with sertraline, a new serotonin uptake inhibitor, reduces voluntary ethanol consumption in rats.
Gill K ; Amit Z ; Koe BK
Alcohol 1988;5(5):349-54     (Journal)     [ ]
220 Effects of fluoxetine on the intragastric self-administration of ethanol in the alcohol preferring P line of rats.
Murphy JM ; Waller MB ; Gatto GJ ; McBride WJ ; Lumeng L ; Li TK
Alcohol 1988;5(4):283-6     (Journal)     [ ]
221 The treatment of cocaine addicts : bromocriptine or desipramine.
Extein IL ; Gold MS
In: Gold MS (ed.) COCAINE UPDATE. Thorofare, NJ : SLACK, Inc., 1988, pp. 535-7. (Psychiat Ann 1988;18(9).     (Chapter) [Call No: RC 568 C6 C628 1988]     [ ]
222 The use of tricyclic antidepressants in methadone maintained pregnant women and infant outcome.
Green L ; Ehrlich S ; Finnegan L
NIDA Res Monogr Ser 1988;81:266-72     (Chapter) [Call No: HV 5825 C617 1987]     [ ]
Free Link
223 Treating cocaine abusing methadone maintenance patients with desipramine.
Kosten T ; Gawin F ; Schumann B
NIDA Res Monogr Ser 1988;81:237-41     (Chapter) [Call No: HV 5825 C617 1987]     [ ]
Free Link
224 Antidepressants.
Cooperrider C
In: Lawson GW ; Cooperrider CA (eds.) CLINICAL PSYCHOPHARMACOLOGY: A PRACTICAL REFERENCE FOR NONMEDICAL PSYCHOTHERAPISTS. Rockville : Aspen Publishers, 1988, pp. 91-108.     (Chapter) [Call No: RM 315 C554 1988]     [ ]
225 A preliminary study of desipramine in the treatment of cocaine abuse in methadone maintenance patients.
Kosten TR ; Schumann B ; Wright D ; Carney MK ; Gawin FH
J Clin Psychiatry 1987;48(11):442-4     (Reprint 02413)     [ ]
226 Neonatal antidepressant administration suppresses concurrent active (REM) sleep and increases adult alcohol consumption in rats.
Hilakivi LA ; Hilakivi I ; Kiianmaa K
In: Lindros KO : Ylikahri R ; Kiianmaa K (eds.) ADVANCES IN BIOMEDICAL ALCOHOL RESEARCH. Third Congress of the International Society for Biomedical Research on Alcoholism, Helsinki, 8-13 June 1986. Oxford, England : Pergamon Press, 1987, pp. 339-43.     (Chapter) [Call No: RC 565 A339 1987]     [ ]
227 Down-regulation of cerebral beta-adrenoceptors induced by long term administration of antidepressants is prevented by ethanol.
Rommelspacher H ; Strauss S
In: Lindros KO ; Ylikahri R ; Kiianmaa K (eds.) ADVANCES IN BIOMEDICAL ALCOHOL RESEARCH. Third Congress of the International Society for Biomedical Research on Alcoholism, Helsinki, 8-13 June 1986. Oxford, England : Pergamon Press, 1987, pp. 697-701.     (Chapter) [Call No: RC 565 A339 1987]     [ ]
228 Binding of imipramine to platelet membranes is lower in alcoholics than in controls.
Javors M ; Blaisdell G ; Lee J ; Bowden C
Alcohol Drug Res 1987;7(5-6):453-9     (Journal)     [ ]
229 Treatment of depression in chronic cocaine and phencyclidine abuse with desipramine.
Giannini AJ ; Malone DA ; Giannini MC ; Price WA ; Loiselle RH
J Clin Pharmacol 1986;211-14     (Reprint 01744)     [ ]
230 Determination of carbamazepine by HPLC electrochemical detection and application for estimation of imipramine, desipramine, doxepin and nordoxepin.
Messiha FS
Alcohol 1986;3(2):135-8     (Journal)     [ ]
231 The effects of antidepressants taken with and without alcohol on information processing, psychomotor performance and car handling ability.
Hindmarch I ; Subhan Z
In: O'Hanlon JF ; de Gier JJ (eds.) DRUGS AND DRIVING. Philadelphia : Taylor & Francis, 1986, pp. 231-40.     (Chapter) [Call No: RA 1057 D65 1986]     [ ]
232 EEG energy-density spectra and driving performance under the influence of some antidepressant drugs.
Brookhis KA ; Louwerens JW ; O'Hanlon JF
In: O'Hanlon JF ; de Gier JJ (eds.) DRUGS AND DRIVING. Philadelphia : Taylor & Francis, 1986, pp. 213-20.     (Chapter) [Call No: RA 1057 D65 1986]     [ ]
233 Several antidepressants' acute effects upon actual driving performance and subjective mental activation.
Louwerens JW ; Brookhuis KA ; O'Hanlon JF
In: O'Hanlon JF ; de Gier JJ (eds.) DRUGS AND DRIVING. Philadelphia : Taylor & Francis, 1986, pp. 203-12.     (Chapter) [Call No: RA 1057 D65 1986]     [ ]
234 Mu/delta opioid site selectivity of some antidepressants.
Codd EE ; Walker RF
NIDA Res Monogr Ser 1986;75:351-4     (Chapter) [Call No: RM 328 N38 P87 1986]     [ ]
Free Link
235 Cocaine - desipramine interaction.
Misra AL ; Vadlamani NL ; Pontani RB
Res Commun Subst Abuse 1986;7(1/2):85-88     (Journal)     [ ]
236 New uses of antidepressants in cocaine abuse.
Gawin FH
Psychosomatics 1986;27(11):24-9     (Reprint 01812)     [ ]
237 Attenuation by antidepressant drugs of alcohol intake in rats.
Daoust M ; Saligaut C ; Chadelaud M ; Chretien P ; Moore N ; Boismare F
Alcohol 1984;1(5):379-383     (Journal)     [ ]
238 Pretreatment with amitriptyline enhances lethality to ethanol in the rat.
Zaccaria A ; Balkon J ; Lynch V ; Bidanset JH
Res Commun Subst Abuse 1984;5(2):133-145     (Journal)     [ ]
239 Inability of monoamine oxidase inhibitors to prevent the persistent depletion of striatal dopamine by amphetamine in rats.
Fuller RW ; Hemrick-Luecke SK
Res Commun Subst Abuse 1984;5(4):247-252     (Journal)     [ ]
240 Cocaine abuse treatment : open pilot trial with desipramine and lithium carbonate.
Gawin FH ; Kleber HD
Arch Gen Psychiatry 1984;41:903     (Reprint 00735)     [ ]
241 Trazodone - oral cocaine interactions.
Rowbotham MC ; Jones RT ; Benowitz NL ; Jacob P
Arch Gen Psychiatry 1984;41:895-9     (Reprint 00969)     [ ]
242 The effects of some antidepressants on the induction of morphine dependence and the morphine withdrawal syndrome.
Davies W ; Gonzalez JP ; Sewell RDE ; Spencer PSJ
Alcohol Alcoholism 1983;18(4):343-351     (Journal)     [ ]
243 Neonatal clomipramine treatment in the rat does not affect social, sexual and exploratory behaviors in adulthood.
File SE ; Tucker JC
Neurobehav Toxicol Teratol 1983 Jan-Feb;5(1):3-8     (Journal)     [ ]
244 Cocaine and amphetamine dependence treated with desipramine.
Tennant FS Jr ; Rawson RA
NIDA Res Monogr Ser 1983;43:351-5     (Chapter) [Call No: HV 5825 C617 1982]     [ ]
245 Safety of high-dose tricyclic antidepressant therapy.
Schuckit MA ; Feighner JP
Am J Psychiatry 1982;128(11):1456-9     (Reprint 01076)     [ ]
246 The antidepressant action of cesium chloride and ethanol preference in rodents.
Messiha FS
In: Messiha FS ; Tyner GS (eds.) ALCOHOLISM: A PERSPECTIVE. Westbury : PJD Publications, 1980, pp.247-259.     (Chapter) [Call No: RC 565 C55 no.1/2]     [ ]
247 Monoamine oxidase inhibitors: influence on ethanol-induced sleep time and ethanol metabolism.
Petersen DR ; Fish BS ; Collins AC
Curr Alcohol 1978;3:153-172.     (Chapter) [Call No: RC 564 C87 v.3]     [ ]
New Search